Antifungal agents
Details for Australian Patent Application No. 2008289616 (hide)
International Classifications
Event Publications
1 July 2010 Section 223 Application Allowed
Merck Sharp And Dohme De Espana, Sa; Merck Frosst Canada Ltd.; Merck And Co., Inc. The time in which to enter the National Phase has been extended to 16 Apr 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Extensions of Time, Section 223
8 July 2010 PCT application entered the National Phase
PCT publication WO2009/025733 Priority application(s): WO2009/025733
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser